Canada markets close in 2 hours 36 minutes

Aptose Biosciences Inc. (APTO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1960-0.0040 (-0.33%)
As of 11:34AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 19.43M
Enterprise Value 11.20M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.35
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.22

Trading Information

Stock Price History

Beta (5Y Monthly) 1.42
52-Week Change 3126.42%
S&P500 52-Week Change 323.10%
52 Week High 36.6000
52 Week Low 30.3600
50-Day Moving Average 31.5180
200-Day Moving Average 32.5748

Share Statistics

Avg Vol (3 month) 378.66k
Avg Vol (10 day) 348.73k
Shares Outstanding 515.72M
Implied Shares Outstanding 616.2M
Float 812.52M
% Held by Insiders 119.07%
% Held by Institutions 17.41%
Shares Short (Apr 15, 2024) 454.93k
Short Ratio (Apr 15, 2024) 40.65
Short % of Float (Apr 15, 2024) 40.35%
Short % of Shares Outstanding (Apr 15, 2024) 40.35%
Shares Short (prior month Mar 15, 2024) 450.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 06, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-102.23%
Return on Equity (ttm)-293.95%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -52.27M
Net Income Avi to Common (ttm)-51.21M
Diluted EPS (ttm)-7.5800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.25M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)1.01M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.78
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-44.59M
Levered Free Cash Flow (ttm)-25.82M